Omixon

We are proud to share the findings from the multicenter study on high-resolution HLA genotyping using third-generation sequencing technology conducted by Stéphane Buhler, Maja Nørgaard, Rudi Steffensen, Kirstine Kløve-Mogensen, Bjarne Møller, Rebecca Grossmann, Sylvie Ferrari-Lacraz, and Claudia Lehmann.   The study explored the efficacy of nanopore sequencing for HLA typing and used the NanoTYPE™ kit and NanoTYPER™ software to compare the results with next-generation sequencing (NGS) across 381 samples. The findings were impressive, with a 99.58% concordance for 11 HLA loci (HLA-A, -B, -C, -DRB1, -DRB3, -DRB4, -DRB5, -DQA1, -DQB1, -DPA1, and -DPB1).   This high level of accuracy underscores the potential of nanopore sequencing in diagnostic laboratories, particularly for stem cell transplantation and investigating various disease associations.   https://lnkd.in/gENm_5Ec   #Genomics #HLAtyping #NanoTYPE #NanoTYPER #ThirdGenerationSequencing #HealthcareInnovation #StemCellResearch #ClinicalResearch #NanoporeSequencing

We are pleased to announce that Cem Mak of JETA Molecular will present the translational research talk titled, “Application of dPCR for Monitoring Transplant Success,” at the QIAGEN dPCR Used Day 2024, scheduled for August 29th in Breda. We cordially invite you to attend and learn why dPCR is superior to NGS and other methods for high-sensitivity, transplant monitoring research.

This study contributed data for the first IVDR approval of NanoTYPE, as the first IVD HLA typing product on Oxford Nanopore sequencing platform. I thank our collaborators and I am proud of the accomplishment of the Omixon team.

XXVIII SBTMO CONGRESS 2024 - Fortaleza, Brazil.   On the second day, the excitement continues with engaging poster sessions, interactive user group meetings, and live demonstrations. These sessions provide valuable insights and conversations helping our understanding and collaboration in the field.   Our Technical Sales Representatives, Gustavo Silva and Giovanna Lopes Bomgiovanni, are eager to discuss scientific and technical matters, and demonstrate our cutting-edge NanoTYPE workflow protocol and NanoTYPER software at our booth #29. Don't miss the chance to meet our team and explore the latest in genomic solutions!   www.omixon.com   #SBTMO2024 #OmixonBrazil #MolecularDiagnostics #HLAtyping #NanoTYPE #NanoTYPER #BoneMarrowTransplant #HoloGRAFT #CellTherapy #ScientificInnovation #Networking #FortalezaCongress #LaboratoryExcellence

Omixon's Brazil Team is happy to announce our participation in the XXVIII SBTMO CONGRESS 2024 in beautiful Fortaleza! The congress is dedicated to advancing bone marrow transplantation and cell therapy and it brings together top LATAM professionals and experts in the field for an exchange of knowledge and innovation.   Our Technical Sales Representatives, Gustavo Silva and Giovanna Lopes Bomgiovanni, are eager to connect with our laboratory partners, discuss scientific and technical matters, and demonstrate our cutting-edge NanoTYPE workflow protocol and NanoTYPER software at our booth #29. This is also a fantastic opportunity to engage with our partner laboratory teams outside the usual work setting and discuss various topics in a relaxed atmosphere. Don't miss the chance to meet our team and explore the latest in genomic solutions! www.omixon.com   #SBTMO2024 #OmixonBrazil #MolecularDiagnostics #HLAtyping #NanoTYPE #NanoTYPER #BoneMarrowTransplant #HoloGRAFT #CellTherapy #ScientificInnovation #Networking #FortalezaCongress #LaboratoryExcellence

We are happy to announce our participation at the SBTMO 2024 conference, taking place from July 31 to August 3 in beautiful Fortaleza!   Our team is ready to showcase the market leading NanoTYPE HLA typing kit through a live demo using Oxford Nanopore sequencing technology. This cutting-edge kit offers unparalleled precision and speed in HLA typing. Join us at our booth #29 to: Witness the NanoTYPE HLA typing Kit and the NanoTYPER software in action. Discover the latest advancements in nanopore sequencing. Get all your questions answered by our experts. Don't miss this opportunity to see how our innovative solutions can transform your research and clinical applications. We're looking forward to connecting with you and exploring new possibilities together! Temos o prazer de anunciar nossa participação no congresso da SBTMO 2024, que será realizado na linda cidade de Fortaleza, de 31 de julho a 3 de agosto! Nossa equipe está pronta para apresentar o revolucionário NanoTYPE, o novo kit de genotipagem HLA pela tecnologia de sequenciamento Oxford Nanopore. Este kit NGS de última geração oferece precisão e velocidade incomparáveis na tipificação HLA. 🔬 Junte-se a nós em nosso estande #29 para: Descubrir os últimos avanços em sequenciamento de nanoporos; Tirar todas as suas dúvidas com nossos especialistas; Não perca a oportunidade de ver como funciona esta inovadora tecnologia que pode transformar suas pesquisas e aplicações clínicas. Estamos ansiosos para encontrar você e explorar novas possibilidades juntos! https://lnkd.in/gENm_5Ec https://lnkd.in/dXQ3A8Bf   #SBTMO2024 #NanoporeSequencing #HLAtyping #InnovationInGenomics #LiveDemo #Fortaleza #Biotechnology #ResearchAndDevelopment

🎉 Celebrating 50 Years of Innovation at ASHI! From our first annual meeting to groundbreaking advances in HLA typing, we've led the way in immunogenetics. Here's to continuing our journey of discovery and progress for many more years! 🌟 #ASHI50 #Milestone #Immunogenetics

News from University Hospital in Martin, Slovakia.   We are having a fantastic NanoTYPE CE IVD demo at Martin University Hospital, highlighting the growing adoption of NanoTYPE for routine HLA typing. Meeting on-site with our accounts is crucial to ensure seamless implementation and address any technical questions that arise.   Special thanks to Libor Kolesár, our Assay Product Manager, and Peter Romada, Sales Manager EMEA-APAC, for their dedication and expertise. With their support, our partners are always in good hands.   It's an exciting time to explore nanopore sequencing and push the boundaries of what's possible in HLA typing! https://lnkd.in/d6we2_y6   #NanoTYPE #HLAtyping #NanoporeSequencing #HealthcareInnovation #TeamWork #OnSiteSupport

NanoTYPE is now CE marked under IVDR! Omixon has received In Vitro Diagnostic Regulation (IVDR) approval of NanoTYPE, an innovative high resolution multiplex 11 loci human leukocyte antigen (HLA) amplification kit. These assays are among the first HLA genotyping kits to be approved under the new, more comprehensive regulation that came into force in May 2022. It confirms Omixon’s NanoTYPE meets the established safety, efficacy, and quality requirements for approval. Compatible with Oxford Nanopore’s MinION and GridION platforms, NanoTYPE addresses a thriving $200 million market in molecular transplant diagnostics. Outside transplantation HLA genotyping plays an increasing role in immuno-oncology, disease association and as companion diagnostics. Read our full communication here: https://lnkd.in/d6we2_y6 🏆Congratulations to the Omixon Team, especially our Quality and Regulatory colleagues, for their dedication and hard work in making this breakthrough possible!🏆 #Omixon #TransplantDiagnostics #HLAgenotyping #CEIVD #IVDR #Innovation #HealthcareTech #OxfordNanopore

We are happy to announce our participation in the ASHI Educational Workshop! This event is designed to introduce emerging technologies and concepts, catering to the growing educational needs of the ASHI community. Our Field Application Scientist, Péter Benkő, and Technical Sales Specialist, Patrick Manoil, will be representing Omixon's US Team, sharing their expertise and experience. The ASHI Educational Workshop is renowned for its interactive and educational atmosphere, perfect for both novice and experienced bench technologists and supervisors. Attendees can look forward to engaging sessions that cover essential theory and practical applications in the laboratory.   🗓️ Date: June 6 - 8, 2024 📍 Location: Embassy Suites by Hilton Raleigh-Durham Research Triangle We look forward to seeing you there!   #Omixon #ASHIWorkshop #EmergingTechnologies #EducationalExcellence #LaboratoryScience #HealthcareInnovation